Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability

Surgery

Volumn 136, Issue 5, 2004, Pages 1054-1060

  Newton, Christopher R ^a   Curran, Brian ^a   Victorino, Gregory P ^a,b  

^a ALAMEDA COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HYDRAULIC PERMEABILITY; MESENTERY BLOOD VESSEL; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; CELL MEMBRANE PERMEABILITY; FEMALE; IMIDAZOLES; KINETICS; MICROCIRCULATION; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SPLANCHNIC CIRCULATION; VENULES;

EID: 7544244885     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2004.04.031     Document Type: Article

References (26)

1. Michel C.C., Curry F.E. Microvascular permeability. Physiol Rev. 79:1999;703-756
2. Hilton J.G., Marullo D.S. Trauma induced increases in plasma vasopressin and angiotensin II. Life Sci. 41:1987;2195-2200
3. Victorino G.P., Newton C.R., Curran B. Dose dependent actions and temporal effects of angiotensin II on microvascular permeability. J Trauma. 55:2003;527-530
4. Victorino G.P., Newton C.R., Curran B. The effect of the angiotensin II on microvascular permeability. J Surg Res. 104:(2):2002;77-81
5. Nouet S., Nahmias C. Signal transduction from the angiotensin II AT2 receptor. Trends in endocrinology and metabolism. 11:2000;1-6
6. Buonassisi V., Venter J.C. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc Natl Acad Sci U S A. 73:1976;1612-1616
7. He P., Zeng M., Curry F.E. cGMP modulates basal and activated microvessel permeability independently of Ca+. Am J Physiol. 274:(6 pt 2):1998;H1865-H1874
8. Williams B., Baker A.Q., Gallacher B., Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscles. Hypertension. 25:1995;913-917
9. Dudley D.T., Panek R.L., Major T.C., Lu G.H., Bruns R.F., Klinkefus B.A., Hodges J.C., Weishaar R.E. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol. 38:1990;370-377
10. Dudley D.T., Hubell S.E., Summerfelt R.M. Characterization of Angiotensin II (AT2) binding sites in R3T3 cells. Mol Pharmacol. 40:1991;360-367
11. Kambayashi Y., Takahashi K., Bardhan S., Inagami T. Molecular structure and function of angiotensin type 2 receptor. Kidney International. 46:1994;1502-1504
12. Curry F.E., Huxley V.H., Sarelius I.H. Techniques in microcirculation: measurement of permeability, pressure and flow. Linden R.T. Cardiovascular Physiology. Techniques in the Life Sciences. Vol P309(1):1983;1-34 Elsevier, New York
13. Newton CR, Curran B, Victorino GP. Angiotensin II type 2 receptor effect on microvascular hydraulic permeability. J Surg Res. In press.
14. Caputo L., Benessiano J., Boulanger C.M., Levy B.I. Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. Arteriosclerosis, Thrombosis and Vascular Biology. 15:1995;1646-1651
15. Patel J.M., Yarid F.R., Block E.R., Raizada M.K. Angiotensin receptors in pulmonary arterial and aortic endothelial cells. Am J Physiol. 256:1989;C987-C993
16. Chorvatova A., Gallo-Payet N., Casanova C., Payet M.D. Modulation of membrane potential and ionic currents by the AT1 and AT2 receptors of angiotensin II. Cell Signal. 8:1996;525-532
17. Harris R.C. Potential mechanisms and physiologic actions of intracellular angiotensin II. Am J Med Sci. 318:1999;374-379
18. Adamson R.H., Liu B., Fry G.N., Rubin L.L., Curry F.E. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol. 274:(6 pt 2):1998;H1885-H1894
19. He P., Liu B., Curry F.E. Effect of nitric oxide synthetase inhibitors on endothelial Ca+2 and microvessel permeability. Am J Physiol. 272:1997;H176-H185
20. He P., Zeng M., Curry F.E. Dominant role of cAMP in regulation of microvessel permeability. Am J Physiol. 278:2000;H1124-H1133
21. Li J.S., Touyz R.M., Schiffrin E.L. Effects of AT1 and AT2 Angiotensin receptor antagonists in angiotensin II infused rats. Hypertension. 31:(1 pt 2):1998;487-492
22. Matrougui K., Loufrani L., Heymes C., Levy B.I., Henrion D. Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension. 34:(4 pt 1):1999;659-665
23. Dimitropoulou C., White R.E., Fuchs L., Zhang H., Catravas J.D., Carrier G.O. Angiotensin II relaxes microvessels via the AT2 receptor and CA2+-activated K+ (Bkca) channels. Hypertension. 37:2001;301-307
24. Timmermans P.B. Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics. Hypertens Res. 22:1999;147-153
25. Timmermans P.B. Pharmacological properties of angiotensin II receptor antagonists. Can J Cardiol. 15:(Suppl F):1999;26F-28F
26. Fantone J.C., Schrier D., Weingarten B. Inhibition of vascular permeability changes in rats by captopril. J Clin Invest. 69:1982;1207-1211